CN118044611A - 一种清肺护肺的营养品 - Google Patents
一种清肺护肺的营养品 Download PDFInfo
- Publication number
- CN118044611A CN118044611A CN202410205369.XA CN202410205369A CN118044611A CN 118044611 A CN118044611 A CN 118044611A CN 202410205369 A CN202410205369 A CN 202410205369A CN 118044611 A CN118044611 A CN 118044611A
- Authority
- CN
- China
- Prior art keywords
- parts
- lung
- clearing
- cough
- protecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 45
- 230000035764 nutrition Effects 0.000 title claims abstract description 25
- 210000004072 lung Anatomy 0.000 claims abstract description 96
- 206010011224 Cough Diseases 0.000 claims abstract description 73
- 230000000694 effects Effects 0.000 claims abstract description 47
- 206010062717 Increased upper airway secretion Diseases 0.000 claims abstract description 37
- 208000026435 phlegm Diseases 0.000 claims abstract description 37
- 239000002994 raw material Substances 0.000 claims abstract description 30
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 24
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 21
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 21
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 21
- 235000008434 ginseng Nutrition 0.000 claims abstract description 21
- 241001506047 Tremella Species 0.000 claims abstract description 20
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 19
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 19
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 18
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 18
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 18
- 241000490229 Eucephalus Species 0.000 claims abstract description 17
- 241000234435 Lilium Species 0.000 claims abstract description 17
- 244000197580 Poria cocos Species 0.000 claims abstract description 17
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 17
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 17
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 17
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 17
- 235000011477 liquorice Nutrition 0.000 claims abstract description 17
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 16
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 16
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 16
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 15
- 241001547127 Fritillaria cirrhosa Species 0.000 claims abstract description 15
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 15
- 241001080798 Polygala tenuifolia Species 0.000 claims abstract description 15
- 240000002948 Ophiopogon intermedius Species 0.000 claims abstract description 14
- 241000756042 Polygonatum Species 0.000 claims abstract description 14
- 235000008737 Polygonatum biflorum Nutrition 0.000 claims abstract description 14
- 235000012907 honey Nutrition 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract description 6
- 239000000047 product Substances 0.000 claims description 29
- 239000000706 filtrate Substances 0.000 claims description 25
- 238000001914 filtration Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 210000000582 semen Anatomy 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 11
- 238000002791 soaking Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 5
- 210000000952 spleen Anatomy 0.000 abstract description 16
- 208000024891 symptom Diseases 0.000 abstract description 16
- 210000002784 stomach Anatomy 0.000 abstract description 13
- 210000002216 heart Anatomy 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 230000003020 moisturizing effect Effects 0.000 abstract description 5
- 206010008479 Chest Pain Diseases 0.000 abstract description 4
- 208000003251 Pruritus Diseases 0.000 abstract description 3
- 230000007803 itching Effects 0.000 abstract description 3
- 206010060891 General symptom Diseases 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 17
- 240000004371 Panax ginseng Species 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 13
- 241001092070 Eriobotrya Species 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 208000006673 asthma Diseases 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000035922 thirst Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 9
- 206010068319 Oropharyngeal pain Diseases 0.000 description 6
- 201000007100 Pharyngitis Diseases 0.000 description 6
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 5
- 208000013116 chronic cough Diseases 0.000 description 5
- 210000003437 trachea Anatomy 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000171 quenching effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010039424 Salivary hypersecretion Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 201000003453 lung abscess Diseases 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002417 nutraceutical Substances 0.000 description 3
- 235000021436 nutraceutical agent Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 208000026451 salivation Diseases 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037569 Purulent discharge Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- YLKVIMNNMLKUGJ-FPLPWBNLSA-N (15:1)-Cardanol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-FPLPWBNLSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- YLKVIMNNMLKUGJ-UHFFFAOYSA-N 3-Delta8-pentadecenylphenol Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000132092 Aster Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000123589 Dipsacus Species 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 241001633680 Polygonatum odoratum Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241001284352 Terminalia buceras Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000534 thyroid cartilage Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种清肺护肺的营养品及其制备方法,所述营养品包括以下重量份数的原料:紫菀45‑55份、枇杷叶40‑50份、川贝母30‑45份、麦冬25‑35份、玉竹20‑30份、薏苡仁15‑30份、银耳15‑30份、远志15‑24份、桔梗10‑16份、罗汉果10‑16份、白茯苓5‑15份、百合3‑12份、甘草5‑10份、甜杏仁3‑10份、白果1‑10份、蜂蜜1‑5份、人参0.5‑3份、蛹虫草0.5‑5份。所述营养品的原料之间具有协同增效作用,从肺、肝、心、肾、脾、胃等多个维点进行综合调理,可增强滋阴润肺,清热解毒,消痰止咳的功效,可提升治疗效果;同时,患者使用该营养品后,咳嗽、咯痰、咽痒和胸闷等全身症状基本消失,治疗总有效率高达95%,可明显改善患者症状,提高生活质量。
Description
技术领域
本发明涉及营养保健技术领域,更具体地说是涉及一种清肺护肺的营养品及其制备方法。
背景技术
肺的主要生理功能是主气司呼吸,在人体化生元气、水液代谢方面起到很大的作用。如《素问·经脉别论》曰:“经气归于肺,肺朝百脉,输精于皮毛。”又云:“脾气散精,上归于肺,通调水道,五经并行。”中医理论认为,肺为娇脏,为阳中之太阴,外主一身之皮毛,内为五脏之华盖,若功能失常,临床主要表现为虚实两类。虚证主要为气虚、阴虚,其中气虚多为久病亏耗,或被它脏之病所累;阴虚多系津液消耗,肺失濡养所致;实证则多由痰浊水湿内聚、寒邪外束和邪热乘肺引起。若肺气宣肃无权,则会出现轻则咳嗽甚则咳喘,迁延日久不愈,常会导致气阴两虚等证。因此,咳嗽气喘、痰黏稠、胸胁支满,当以泻肺降火、调肺化痰治之;久咳伤阴或者热病后期,或肺之气阴不足、虚热内灼而致肺失润降等,当以滋阴润肺治之。
现有技术中,专利号为CN105477324A公开了一种治疗咳嗽的中药,其由甘草、杏仁、陈皮、玉竹、紫苑、五味子和太子参组成,其虽然能达到止咳的效果,但该中药组合物养阴清肺效果不足。专利号为CN103690592A公开了一种清咽润肺组合物,由量天尺花、蝴蝶果、乌榄、甘草、罗汉果组成,其主要是消肿止痛、止咳化痰,并不能达到滋阴养肺的效果。
因此,如何提供一种在化痰止咳的同时还具有清肺护肺功效的营养品是本领域技术人员亟需解决的问题。
发明内容
有鉴于此,本发明提供了一种清肺护肺的营养品及其制备方法。
为了实现上述目的,本发明采用如下技术方案:
一种清肺护肺的营养品,包括以下重量分数的原料:紫菀45-55份、枇杷叶40-50份、川贝母30-45份、麦冬25-35份、玉竹20-30份、薏苡仁15-30份、银耳15-30份、远志15-24份、桔梗10-16份、罗汉果10-16份、白茯苓5-15份、百合3-12份、甘草5-10份、甜杏仁3-10份、白果1-10份、蜂蜜1-5份、人参0.5-3份、蛹虫草0.5-5份。
优选地,所述营养品包括以下重量分数的原料:紫菀52份、枇杷叶43份、川贝母34份、麦冬27份、玉竹20份、薏苡仁17份、银耳21份、远志18份、桔梗14份、罗汉果16份、白茯苓7份、百合9份、甘草8份、甜杏仁5份、白果4份、蜂蜜3份、人参2份、蛹虫草1份。
优选地,所述营养品包括以下重量分数的原料:紫菀55份、枇杷叶40份、川贝母40份、麦冬35份、玉竹27份、薏苡仁15份、银耳27份、远志15份、桔梗10份、罗汉果14份、白茯苓5份、百合12份、甘草5份、甜杏仁8份、白果1份、蜂蜜5份、人参0.5份、蛹虫草3份。
优选地,所述营养品包括以下重量分数的原料:紫菀45份、枇杷叶50份、川贝母30份、麦冬25份、玉竹30份、薏苡仁24份、银耳15份、远志24份、桔梗16份、罗汉果10份、白茯苓15份、百合3份、甘草10份、甜杏仁3份、白果10份、蜂蜜1份、人参1份、蛹虫草2份。
作为与上述技术方案相同的发明构思,本发明还请求保护一种清肺护肺的营养品的制备方法,包括以下步骤:
(1)按照上述重量份数称取原料,备用;
(2)取紫菀、枇杷叶、川贝母、麦冬、玉竹、薏苡仁、银耳、人参和蛹虫草置于煎药壶中,加水浸泡,回流提取,过滤得到滤液A;
(3)取远志、桔梗、罗汉果、甘草、白茯苓、百合、甘草、甜杏仁和白果置于煎药壶中,加水浸泡,回流提取,过滤得到滤液B;
(3)将滤液A和滤液B混合,煎煮0.5-1h后得到煎煮液C;
(4)将滤液C浓缩至60-70℃时相对密度为1.1-1.3的清膏,静置,得浓缩液;
(5)将浓缩液过滤,加入蜂蜜混匀,滤过,灌封,灭菌,即得营养品。
优选地,步骤(2)中,所述加水量为该步骤中药材总量的8-10倍。
优选地,步骤(2)-(3)中,所述浸泡时间为0.5-1h,提取时间为1-2h。
优选地,步骤(3)中,所述加水量为该步骤中药材总量的6-8倍。
作为与上述技术方案相同的发明构思,本发明还请求保护所述营养品在制备润肺止咳、祛痰药物中的应用。
作为与上述技术方案相同的发明构思,本发明还请求保护所述营养品在制备具有养阴润肺作用的保健品或食品中的应用。
本发明中各原料的药理作用如下:
紫菀:味苦,性温,润肺下气,消痰止咳;用于痰多喘咳,新久咳嗽,劳嗽咳血;紫菀能明显增加支气管分泌,有较好的祛痰作用。
枇杷叶:味苦,性微寒,归肺、胃经,具有清肺止咳,和胃利尿,止渴的功效,用于治疗肺热咳嗽、痰多色黄;其含倍半萜及苦杏仁苷等成分,具有清肺止咳,降逆止呕的功效。
川贝母:味苦、甘,性微寒,归肺、心经,具有清热化痰,润肺止咳,散结消肿的功效;用于虚劳久咳,肺热燥咳,肺痈吐脓,瘰疬结核,乳痈,疮肿;
麦冬:味甘、微苦,性微寒,归胃、肺、心经,具有养阴润肺、益胃生津、清心除烦的功效,用于肺燥干咳、阴虚痨嗽、喉痹咽痛、津伤口渴、内热消渴、心烦失眠、肠燥便秘等症。
玉竹:味甘,性微寒,归肺经、胃经,具有养阴润燥,生津止渴的功效,用于肺胃阴伤,燥热咳嗽,咽千口渴,内热消渴等,用作滋补药品,主治热病伤阴、虚热燥咳、心脏病、糖尿病、结核病等症,并可作高级滋补食品、佳肴和饮料,具有保健作用。
薏苡仁:味甘、淡,性凉,归脾、胃、肺经,具有健脾渗湿、清热排脓、除痹、利水的功效;用于水肿脚气,食少泄泻,湿痹拘挛,肺痈,肠痈。
银耳:味甘、淡,性平,归肺、胃、肾经,具有滋阴润肺、滋补生津、益气和血的功效,用于虚劳咳嗽;痰中带血;津少口渴;病后体虚;气短乏力。
远志:味苦、辛,性温,归心、肾、肺经,具有安神益智、祛痰消肿的功效,用于心肾不交,失眠多梦,健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。
桔梗:味苦、辛,性平,归肺经,具有宣肺祛痰、利咽排脓之效,用于治疗咳嗽痰多、胸膈满闷、咽痛音哑、肺疽吐脓。
罗汉果:味甘,性凉,归肺、大肠经,有润肺止咳、生津止渴、润肠通便的功效、适用于肺热或肺燥咳嗽、百日咳及暑热伤津口渴等,此外其果实营养价值很高,含丰富的维生素C以及糖甙、果糖、葡萄糖、蛋白质、脂类等。
白茯苓:味甘、淡、性平,归心、脾、肺、肾经,茯苓含茯苓多糖、B-茯苓聚糖、茯苓酸、卵磷脂及甾醇等物质,具有败毒抗癌、利水化饮、健脾化痰、宁心安神的功效,用于痰饮咳嗽,痰湿入络,脾虚泄泻。
百合:味甘、微苦,性微寒,归心、肺经,具有养阴润肺、清心安神的功效;用于阴虚久嗽,痰中带血,热病后期,余热未清。
甘草:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药;用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒。
甜杏仁:味甘,性平,归肺、大肠经,具有润肺止咳定喘,健脾润肠通便的功效,用于虚劳咳嗽、气喘,胸腹逆闷,肠燥便秘。
白果:味甘、苦涩,性平,归肺、肾经,具有祛痰止咳、润肺定喘的功效;白果中所含的白果酸及白果酚等物质,有抗结核杆菌的作用,对改善肺结核病所致的发热、盗汗、咳嗽咯血、食欲不振等症状有一定作用。
人参:味甘、微苦,性微温,归肺、脾经,具有利咽化痰,补脾益肺,生津,安神益智的功效,用于气虚欲脱,脉微欲绝,脾气不足,中气下陷,肺虚喘咳,气短乏力。
蛹虫草:归肺、肾经,具有补肺平喘、健脾安神、扶正益气和提高免疫力的功效;蛹虫草所含谷氨酸有免疫抑制作用,蛹虫草含有的虫草素能有效降低肺纤维化,改善肺的组织结构和纤维化病理变化。
经由上述的技术方案可知,与现有技术相比,本发明公开提供了一种清肺护肺的营养品及其制备方法,其有益效果:
(1)本发明营养品采用纯中药合理配比而成,符合中医君臣配伍及现代药理学。紫菀润肺下气,消痰止咳,重在滋阴;枇杷叶清肺止咳,和胃利尿,止渴,用于肺热咳嗽、痰多色黄;川贝母清热化痰,润肺止咳,主治虚劳久咳,肺热燥咳,肺痈吐脓;麦冬养阴润肺、益胃生津;玉竹养阴润燥,生津止渴,主治燥热咳嗽;薏苡仁上清肺热而排脓,下利肠胃而渗湿;银耳滋阴润肺、滋补生津,重在润肺;远志祛痰消肿,主治咳痰不爽,疮疡肿毒;桔梗升提肺气,有升有降,升降相宜,气机畅通,咳嗽自止;罗汉果清热润肺,止咳,利咽,滑肠通便;白茯苓清热解毒,健脾化痰,重在化痰;百合滋阴润肺、止咳平喘、清热解毒;甘草清热解毒,祛痰止咳,可调和诸药;人参利咽化痰,补脾益肺,重在滋补;蛹虫草补肺平喘、扶正益气。以上诸药合用,从肺、肝、心、肾、脾、胃等多个维点进行综合调理,在增强滋阴润肺,清肺润燥,消痰止咳和益气养阴功效的同时,还能增强人体各个器官的运化能力,加强人体的新陈代谢,协调器官之间运作机能。
(2)本发明营养品的原料配伍相宜,均为药食同源的植物,来源充足,无任何毒副作用,安全性能高,适合长期服用;且制备工艺简单,服用方便。
(3)患者服用本发明的营养品后,咳嗽、咯痰、咽痒和胸闷等全身症状基本消失,治疗总有效率高达95%,可明显改善患者症状,提高生活质量。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种清肺护肺的营养品,包括以下重量分数的原料:紫菀52份、枇杷叶43份、川贝母34份、麦冬27份、玉竹20份、薏苡仁17份、银耳19份、远志18份、桔梗14份、罗汉果16份、白茯苓7份、百合9份、甘草8份、甜杏仁5份、白果4份、蜂蜜3份、人参2份、蛹虫草1份。
制备方法如下所示:
(1)按照上述重量份称取原料,备用;
(2)取紫菀、枇杷叶、川贝母、麦冬、玉竹、薏苡仁、银耳、人参和蛹虫草置于煎药壶中,加入9倍的水浸泡0.6h,回流提取1.5h,过滤得到滤液A;
(3)取远志、桔梗、罗汉果、甘草、白茯苓、百合、甘草、甜杏仁和白果置于煎药壶中,加入7倍的水浸泡0.6h,回流提取1.5h,过滤得到滤液B;
(3)将滤液A和滤液B混合,煎煮0.5h后得到煎煮液C;
(4)将滤液C浓缩至70℃时相对密度为1.1的清膏,静置,得浓缩液;
(5)将浓缩液过滤,加入蜂蜜混匀,滤过,灌封,灭菌,即得营养品。
实施例2
一种清肺护肺的营养品,包括以下重量分数的原料:紫菀55份、枇杷叶40份、川贝母40份、麦冬35份、玉竹27份、薏苡仁15份、银耳27份、远志15份、桔梗10份、罗汉果14份、白茯苓5份、百合12份、甘草5份、甜杏仁8份、白果1份、蜂蜜5份、人参0.5份、蛹虫草3份。
制备方法如下所示:
(1)按照上述重量份称取原料,备用;
(2)取紫菀、枇杷叶、川贝母、麦冬、玉竹、薏苡仁、银耳、人参和蛹虫草置于煎药壶中,加入9倍的水浸泡1h,回流提取2h,过滤得到滤液A;
(3)取远志、桔梗、罗汉果、甘草、白茯苓、百合、甘草、甜杏仁和白果置于煎药壶中,加入6倍的水浸泡1h,回流提取2h,过滤得到滤液B;
(3)将滤液A和滤液B混合,煎煮1h后得到煎煮液C;
(4)将滤液C浓缩至60℃时相对密度为1.3的清膏,静置,得浓缩液;
(5)将浓缩液过滤,加入蜂蜜混匀,滤过,灌封,灭菌,即得营养品。
实施例3
一种清肺护肺的营养品,包括以下重量分数的原料:紫菀45份、枇杷叶50份、川贝母30份、麦冬25份、玉竹30份、薏苡仁30份、银耳21份、远志24份、桔梗16份、罗汉果10份、白茯苓15份、百合3份、甘草10份、甜杏仁3份、白果10份、蜂蜜1份、人参1份、蛹虫草2份。
制备方法如下所示:
(1)按照上述重量份称取原料,备用;
(2)取紫菀、枇杷叶、川贝母、麦冬、玉竹、薏苡仁、银耳、人参和蛹虫草置于煎药壶中,加入10倍的水浸泡0.8h,回流提取1h,过滤得到滤液A;
(3)取远志、桔梗、罗汉果、甘草、白茯苓、百合、甘草、甜杏仁和白果置于煎药壶中,加入8倍的水浸泡0.8h,回流提取1h,过滤得到滤液B;
(3)将滤液A和滤液B混合,煎煮0.8h后得到煎煮液C;
(4)将滤液C浓缩至65℃时相对密度为1.2的清膏,静置,得浓缩液;
(5)将浓缩液过滤,加入蜂蜜混匀,滤过,灌封,灭菌,即得营养品。
实施例4
一种清肺护肺的营养品,包括以下重量分数的原料:紫菀48份、枇杷叶46份、川贝母37份、麦冬32份、玉竹23份、薏苡仁24份、银耳30份、远志20份、桔梗12份、罗汉果12份、白茯苓11份、百合6份、甘草6份、甜杏仁10份、白果8份、蜂蜜2份、人参3份、蛹虫草5份。
制备方法与实施例1相同。
对比例1
一种清肺护肺的营养品,包括以下重量分数的原料:紫菀60份、枇杷叶55份、川贝母25份、麦冬22份、玉竹32份、薏苡仁13份、银耳10份、远志13份、桔梗18份、罗汉果10份、白茯苓3份、百合15份、甘草12份、甜杏仁11份、白果14份、蜂蜜3份、人参4份、蛹虫草0.3份。
制备方法与实施例1相同。
对比例2
与实施例1相比,去除紫菀、枇杷叶,其余组分配比不变;
对比例3
与实施例1相比,去除桔梗、罗汉果,其余组分配比不变;
对比例4
与实施例1相比,将枇杷叶、川贝母分别替换成紫苏叶、柴胡,其余组分配比不变;
对比例5
与实施例1相比,去除百合、白茯苓和蛹虫草,其余组分配比不变。
试验例1不同营养品对小鼠祛痰作用的影响
取健康ICR小鼠110只,体重18~22g,随机分为11组,即空白组,氯化铵阳性对照组(0.5g/kg),实施例1-4制备的营养品(3.0g/kg)以及对比例1-5制备的营养品(3.0g/kg),除空白组给予等体积的纯净水外,其他给药组均按上述给药剂量连续灌胃给药7天,给药体积为10ml/kg。末次给药前禁食12h,末次给药后0.5小时腹腔注射5%酚红生理盐水溶液10ml/kg,0.5h后断颈处死小鼠,剥离气管周围组织,剪下自甲状腺软骨至气管分支处一段气管,放入盛有碱性生理盐水(生理盐水2ml+1N氢氧化钠0.1ml)溶液的试管中,经室温放置2h后,将气管洗脱液用紫外可见分光光度计于546nm波长处测其吸光度,通过酚红标准曲线计算每只小鼠气管酚红含量,测定结果入表1所示。
表1不同营养品对小鼠祛痰作用的影响
由表1可知,实施例1-4所制备的营养品与空白对照组比较,均有极显著性差异,表明该营养品能明显促进小鼠气管的酚红排泌量,说明本发明的营养品有很好的祛痰作用。对比例1-5中,当改变原料配比或去除一种原料或替换一种原料所制备而成的营养品其虽然能促进小鼠气管的酚红排泌量,但与空白组差异较小,且与本发明相比,其对小鼠气管的酚红排泌量均显著下降,由此可说明,本发明的营养品的各原料组分之间是相辅相成,共同发挥作用的。
试验例2不同营养品对氨水引发小鼠咳嗽的影响
取健康ICR小鼠100只,体重18~22g,随机分为10组,即模型对照组,实施例1-4制备的营养品(3.0g/kg)以及对比例1-5制备的营养品(3.0g/kg),除模型对照组给予等体积的纯净水外,其他给药组均按上述给药剂量连续灌胃给药7天,给药体积为10ml/kg。各组于末次给药后1h,将小鼠置于倒置的500ml烧杯内,吸取0.3ml浓氨水注入50mg棉球后放入烧杯内,观察并记录各组小鼠的咳嗽潜伏期和5min内小鼠咳嗽次数(典型咳嗽是小鼠腹肌收缩,同时张大嘴,伴有咳声)。测定结果如表2所示。
表2不同营养品对氨水引发小鼠咳嗽的影响
组别 | 剂量(g/kg) | 动物只数 | 潜伏期(S) | 5min咳嗽次数 |
模型对照组 | -- | 10 | 83.4 | 31.6 |
实施例1 | 3 | 10 | 100.7 | 11.2 |
实施例2 | 3 | 10 | 96.4 | 13.8 |
实施例3 | 3 | 10 | 98.1 | 12.4 |
实施例4 | 3 | 10 | 99.6 | 11.9 |
对比例1 | 3 | 10 | 77.8 | 19.6 |
对比例2 | 3 | 10 | 74.2 | 24.8 |
对比例3 | 3 | 10 | 71.9 | 27.1 |
对比例4 | 3 | 10 | 76.0 | 19.5 |
对比例5 | 3 | 10 | 72.1 | 25.7 |
由表2可知,实施例1-4所制备的营养品的咳嗽潜伏期与模型对照组比,均能显著延长小鼠咳嗽潜伏期;实施例1-4组5min内咳嗽的次数与模型对照组比较均有所降低,可说明本发明的营养品均能明显延长氨水诱导的小鼠咳嗽潜伏期及降低咳嗽次数,从而表明本发明的营养品有明显的镇咳作用。对比例1-5中,当改变原料配比或去除一种原料或替换一种原料所制备而成的营养品,其虽然能降低5min内小鼠的咳嗽次数,但其并不能延长小鼠咳嗽潜伏期,由此可说明,本发明的营养品的各原料组分之间是相辅相成,共同发挥作用的。
试验例3不同营养品的功效试验
选取180位咳嗽多痰,症状程度相差不多的患者,分为9组,每组20人,分别服用实施例1-4以及对比例1-5所制备的营养品;每天饮用一次,一次3g,连续饮用7天,根据《中药新药临床研究指导原则》拟定临床症状的评分标准,如表3所示。症状总积分=咳嗽积分+咯痰积分+咽痒积分+胸闷积分,测定结果如表4所示。
表3临床症状的评分标准
根据《中药新药临床研究指导原则》拟定疗效判断标准如下:
痊愈:治疗后临床咳嗽及全身症状基本消失,症状总积分减少≥95%;
显效:治疗后临床咳嗽及全身症状明显好转,70%≤症状总积分减少<95%;
有效:治疗后临床咳嗽及全身症状均有好转,30%≤症状总积分减少<70%;
无效:治疗后临床咳嗽及全身症状无明显改善,甚或加重,症状总积分减少<30%。
表4不同营养品的功效试验结果
由表4可知,患者经服用本发明实施例1-4所制备的营养品治疗后,总有效率高达95.0%;而服用对比例1-5后总有效率为85.0%;虽然服用对比例1-5所制备的营养品治疗后咳嗽症状有明显好转,但治疗效果均显著低于本发明实施例1-4所制备的营养品。
本说明书中各个实施例采用递进的方式描述,每个实施例重点说明的都是与其他实施例的不同之处,各个实施例之间相同相似部分互相参见即可。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (10)
1.一种清肺护肺的营养品,其特征在于,包括以下重量份数的原料:紫菀45-55份、枇杷叶40-50份、川贝母30-45份、麦冬25-35份、玉竹20-30份、薏苡仁15-30份、银耳15-30份、远志15-24份、桔梗10-16份、罗汉果10-16份、白茯苓5-15份、百合3-12份、甘草5-10份、甜杏仁3-10份、白果1-10份、蜂蜜1-5份、人参0.5-3份、蛹虫草0.5-5份。
2.根据权利要求1所述的一种清肺护肺的营养品,其特征在于,包括以下重量份数的原料:紫菀52份、枇杷叶43份、川贝母34份、麦冬27份、玉竹20份、薏苡仁17份、银耳21份、远志18份、桔梗14份、罗汉果16份、白茯苓7份、百合9份、甘草8份、甜杏仁5份、白果4份、蜂蜜3份、人参2份、蛹虫草1份。
3.根据权利要求1所述的一种清肺护肺的营养品,其特征在于,包括以下重量份数的原料:紫菀55份、枇杷叶40份、川贝母40份、麦冬35份、玉竹27份、薏苡仁15份、银耳27份、远志15份、桔梗10份、罗汉果14份、白茯苓5份、百合12份、甘草5份、甜杏仁8份、白果1份、蜂蜜5份、人参0.5份、蛹虫草3份。
4.根据权利要求1所述的一种清肺护肺的营养品,其特征在于,包括以下重量份数的原料:紫菀45份、枇杷叶50份、川贝母30份、麦冬25份、玉竹30份、薏苡仁24份、银耳15份、远志24份、桔梗16份、罗汉果10份、白茯苓15份、百合3份、甘草10份、甜杏仁3份、白果10份、蜂蜜1份、人参1份、蛹虫草2份。
5.一种清肺护肺的营养品的制备方法,其特征在于,包括以下步骤:
(1)按照权利要求1-4任一所述的重量份数称取原料,备用;
(2)取紫菀、枇杷叶、川贝母、麦冬、玉竹、薏苡仁、银耳、人参和蛹虫草置于煎药壶中,加水浸泡,回流提取,过滤得到滤液A;
(3)取远志、桔梗、罗汉果、甘草、白茯苓、百合、甘草、甜杏仁和白果置于煎药壶中,加水浸泡,回流提取,过滤得到滤液B;
(3)将滤液A和滤液B混合,煎煮0.5-1h后得到煎煮液C;
(4)将滤液C浓缩至60-70℃时相对密度为1.1-1.3的清膏,静置,得浓缩液;
(5)将浓缩液过滤,加入蜂蜜混匀,滤过,灌封,灭菌,即得营养品。
6.根据权利要求5所述的一种清肺护肺的营养品的制备方法,其特征在于,步骤(2)中,所述加水量为该步骤中药材总量的8-10倍。
7.根据权利要求5所述的一种清肺护肺的营养品的制备方法,其特征在于,步骤(2)-(3)中,所述浸泡时间为0.5-1h,提取时间为1-2h。
8.根据权利要求5所述的一种清肺护肺的营养品的制备方法,其特征在于,步骤(3)中,所述加水量为该步骤中药材总量的6-8倍。
9.根据权利要求1-8任一所述的营养品在制备润肺止咳、祛痰药物中的应用。
10.根据权利要求1-8任一所述的营养品在制备具有养阴润肺作用的保健品或食品中的应用。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410205369.XA CN118044611A (zh) | 2024-02-26 | 2024-02-26 | 一种清肺护肺的营养品 |
NL2037306A NL2037306A (en) | 2024-02-26 | 2024-03-20 | A nutritional product for clearing and protecting the lungs and a preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410205369.XA CN118044611A (zh) | 2024-02-26 | 2024-02-26 | 一种清肺护肺的营养品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118044611A true CN118044611A (zh) | 2024-05-17 |
Family
ID=90716721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410205369.XA Pending CN118044611A (zh) | 2024-02-26 | 2024-02-26 | 一种清肺护肺的营养品 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN118044611A (zh) |
NL (1) | NL2037306A (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690592B (zh) | 2013-12-25 | 2016-01-20 | 广西博士海意信息科技有限公司 | 一种清咽润肺组合物 |
CN105477324A (zh) | 2015-12-23 | 2016-04-13 | 文有艺 | 一种治疗咳嗽的中药 |
-
2024
- 2024-02-26 CN CN202410205369.XA patent/CN118044611A/zh active Pending
- 2024-03-20 NL NL2037306A patent/NL2037306A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NL2037306A (en) | 2024-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107126485A (zh) | 一种辅助改善睡眠的中药组合物及其制备方法和应用 | |
CN111264735A (zh) | 一种扶正固本提高免疫力防控疫毒的功能饮料 | |
CN105708970B (zh) | 一种具有降血糖功能的保健食品 | |
CN104825778A (zh) | 一种用于治疗犊牛肺炎的中药组合物 | |
CN111588804A (zh) | 一种补元气的药食同源配方 | |
CN116509971A (zh) | 一种具有益智效果的中药组方、中药液和药物制剂 | |
TW202330006A (zh) | 氣虛及/或血虛相關症狀之預防、改善或緩和用之組合物 | |
CN111135235A (zh) | 一种预防和缓解急性酒精中毒或醉酒的组合物 | |
CN1142785C (zh) | 抗疲劳胶囊 | |
CN108478714A (zh) | 一种儿科自闭症康复治疗辅助用中药组合物 | |
CN115089661A (zh) | 辅助调节内分泌代谢并抗癌防癌的人参组合物的应用 | |
CN102670948A (zh) | 一种冬果梨润肺平喘止咳露及其制备方法 | |
CN118044611A (zh) | 一种清肺护肺的营养品 | |
CN104623615A (zh) | 一种治疗哮喘的药物 | |
CN105639517A (zh) | 枇杷膏及其制备方法 | |
CN111084878A (zh) | 一种用于肺及呼吸系统疾病的生物医药、医用全营养食品及制备方法 | |
CN110898195A (zh) | 一种调理脑中风的中药食疗制品及其制备方法 | |
CN104825777A (zh) | 一种具有补气安神功效的保健胶囊及制备方法 | |
CN110721285A (zh) | 一种用于补元气安心神健脾祛湿调节机体免疫力的中药组合物及其制备方法 | |
CN110140922A (zh) | 一种低温酿熟蜂蜜 | |
CN114617934B (zh) | 一种解毒升白汤 | |
KR102439636B1 (ko) | 근육틱 및 우울증 개선용 조성물 및 그 제조방법 | |
CN106620266A (zh) | 一种治疗猪气喘病的中药组合物 | |
CN106421411A (zh) | 一种健胃功能性饮品 | |
CN113368225A (zh) | 一种用于治疗糖尿病和三高的复合方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |